Lack of pharmacokinetic and pharmacodynamic interaction between rizatriptan and paroxetine.

被引：0
|
作者：
Goldberg, MR [1 ]
Lowry, R [1 ]
Musson, DG [1 ]
Birk, KL [1 ]
Fisher, A [1 ]
DePuy, ME [1 ]
Shadle, CR [1 ]
机构：
[1] Merck Res Labs, W Point, PA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1998年 / 63卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII54
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [1] Lack of pharmacokinetic and pharmacodynamic interaction between rizatriptan and paroxetine
    Goldberg, MR
    Lowry, RC
    Musson, DG
    Birk, KL
    Fisher, A
    DePuy, ME
    Shadle, CR
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (02): : 192 - 199
  • [2] Lack of pharmacokinetic and pharmacodynamic interaction between valsartan and warfarin
    Knight, H
    Flesch, G
    Prasad, P
    Lloyd, P
    Douglas, J
    JOURNAL OF HYPERTENSION, 2000, 18 : S89 - S89
  • [3] Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil
    Periclou, AP
    Ventura, D
    Sherman, T
    Rao, N
    Abramowitz, WT
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (09) : 1389 - 1394
  • [4] Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man
    Ehrlich, A
    Fuder, H
    Hartmann, M
    Wieckhorst, G
    Timmer, W
    Huber, R
    Birkel, M
    Bliesath, H
    Steinijans, VW
    Wurst, W
    Lucker, PW
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (3-4) : 277 - 281
  • [5] Lack of pharmacokinetic and pharmacodynamic interaction between pantoprazole and glibenclamide in humans
    Walter-Sack, IE
    Bliesath, H
    Stotzer, F
    Huber, R
    Steinijans, VW
    Ding, R
    Mascher, H
    Wurst, W
    CLINICAL DRUG INVESTIGATION, 1998, 15 (03) : 253 - 260
  • [6] Lack of Pharmacokinetic and Pharmacodynamic Interaction Between Pantoprazole and Glibenclamide in Humans
    I. E. Walter-Sack
    H. Bliesath
    F. Stötzer
    R. Huber
    V. W. Steinijans
    R. Ding
    H. Mascher
    W. Wurst
    Clinical Drug Investigation, 1998, 15 : 253 - 260
  • [7] Pharmacokinetic and pharmacodynamic interaction of eszopiclone and paroxetine in healthy subjects.
    Skolly, SM
    Niewoehner, J
    Maier, G
    PHARMACOTHERAPY, 2004, 24 (10): : 1422 - 1422
  • [8] LACK OF PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION OF PANTOPRAZOLE AND PHENPROCOUMON IN MAN
    EHRLICH, A
    FUDER, H
    HARTMANN, M
    TIMMER, W
    HUBER, R
    BIRKEL, M
    BLIESATH, H
    STEINJIANS, VW
    WURST, W
    LUCKER, PW
    GASTROENTEROLOGY, 1995, 108 (04) : A86 - A86
  • [9] LACK OF A PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN DIMEBON (LATREPIRDINE) AND WARFARIN IN HEALTHY SUBJECTS.
    Plowchalk, D. R.
    Qiu, R.
    Terra, S. G.
    Corrigan, B.
    Fang, J.
    Fullerton, T.
    Liu, J.
    Byon, W.
    Mordenti, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S57 - S57
  • [10] LACK OF A PHARMACOKINETIC/PHARMACODYNAMIC INTERACTION BETWEEN NIMODIPINE AND TIRILAZAD MESYLATE IN HEALTHY-VOLUNTEERS
    FLEISHAKER, JC
    HULST, LK
    PETERS, GR
    JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (08): : 837 - 841
12345